v3.25.1

Equity Investments - Additional Information (Details) - USD ($)	Jan. 31, 2024	Dec. 31, 2023
Investment In Frontier Medicines [member]
Disclosure of financial assets [line items]
Equity investment	$ 40,000,000
Non-listed company [member]
Disclosure of financial assets [line items]
Equity investment		$ 15,000,000

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfFinancialAssetsLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of instruments held by the entity that provide evidence of a residual interest in the assets of another entity after deducting all of its liabilities.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2024-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_EquityInstrumentsHeld
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Details

Name:	ifrs-full_ClassesOfFinancialAssetsAxis=glpg_InvestmentInFrontierMedicinesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ClassesOfFinancialAssetsAxis=glpg_NonListedCompanyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: